High-Alert Medication Series Part III:
Reducing the Risk of Patient Harm from Chemotherapeutic Agents

Thursday, July 23, 2009 from 1:30-3:00 p.m. ET[Register for this teleconference]  PROGRAM OVERVIEW
Cancer chemotherapy poses a unique set of risks to patients, particularly due to the complexity of therapeutic regimens, the variability in dosing, and the toxic nature of the drugs involved. Learn from the experts why errors associated with chemotherapy are so problematic and how to apply high-leverage error-reduction strategies in your organization to mitigate risk and prevent harm.
  • Ann Shastay, RN, MSN, AOCN

    Managing Editor
    Institute for Safe Medication Practices
    Horsham, PA
  • Sylvia Bartel, RPh, MPH

    Director of Pharmacy and Clinical Support Services
    Dana-Farber Cancer Institute
    Boston, MA
This teleconference is approved for 1.5 contact hours of continuing education (CE) for pharmacists, and 1 contact hour for nurses. There is no additional charge for CE. REGISTER TODAY!
For more information, including online registration and deadlines, please click here.
The Institute for Safe Medication Practices (ISMP) is a nonprofit organization that works closely with healthcare practitioners and institutions, regulatory agencies, consumers, and professional organizations to provide education about medication errors and their prevention. ISMP represents more than 35 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. ISMP is a federally certified patient safety organization (PSO), providing legal protection and confidentiality for submitted patient safety data and error reports.For more information on ISMP, or its medication safety alert newsletters and other resources for healthcare professionals and consumers, visit
Do not reply to this email.
Event Date: 
Binary Data